Inhibition of ex vivo neutrophil activation by oral LY293111, a novel leukotriene B(4) receptor antagonist

1The effects of orally administered LY293111 on ex vivo neutrophil Mac-1 upregulation were determined in a total of 24 healthy male subjects within three study periods. 2In the first period, eight volunteers received 60 mg LY293111 or placebo three times daily in 22 total doses over 8 days followed...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: MARDER, P., SPAETHE, S. M., FROELICH, L. L., CERIMELE, B. J., PETERSEN, B. H., TANNER, T., LUCAS, R. A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 1996
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2042691/
https://ncbi.nlm.nih.gov/pubmed/8904617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1996.43210.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi